Science & Medicine

Sanofi out of the JAK-2 MF Biz



Sanofi’s JAK-2 Drug Kaput!

 Farewell to Federatnib…we hardly knew ya’

In a stunning and unexpected announcement this morning, Sanofi pulled the plug on clinical trials and filings for its MF JAK-2 inhibitor SAR 302503(federatnib).

Here’s the text:

Sanofi release over

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: